• Company
• Polivy’s reimb soon to receive CDDC review
• by Eo, Yun-Ho Nov 6, 2023 05:26am

• Policy
• Pulmican & Pulmicort price increase discussed on the 9th
• by Lee, Tak-Sun Nov 6, 2023 05:26am

• Policy
• Prevenar competitor Vaxneuvance is approved in KOR
• by Lee, Hye-Kyung Nov 3, 2023 05:32am

• Policy
• Tramadol classified as narcotics abroad but not in KOR
• by Lee, Hye-Kyung Nov 3, 2023 05:32am

• Company
• Expansion of coverage for SMA treatment Spinraza
• by Nov 3, 2023 05:32am

• Opinion
• [Reporter’s view] WLA Registration
• by Lee, Hye-Kyung Nov 3, 2023 05:32am

• Company
• Cosentyx is approved for hidradenitis suppurativa
• by Eo, Yun-Ho Nov 3, 2023 05:32am

• Company
• Novartis Jakabi expands graft-versus-host disease coverage
• by Nov 2, 2023 05:35am

• Company
• Reblozyl can be prescribed in general hospitals in KOR
• by Eo, Yun-Ho Nov 2, 2023 05:35am

• Policy
• SR version of gabapentin enters Korean market
• by Lee, Tak-Sun Nov 2, 2023 05:35am